遗传性视网膜疾病的基因疗法:利用基因组编辑和纳米技术中的新工具
Cláudia Carvalho1, Luísa Lemos2, Pedro Antas1,2
1iNOVA4Health, NOVA Medical School | Faculdade de Ciências Médicas, NMS | FCM, Universidade Nova de Lisboa, Lisboa, Portugal.
Frontiers in ophthalmology
|July 10, 2024
概括
基因疗法对遗传性视网膜疾病 (IRD) 是有前途的,但免疫反应等挑战仍然存在. 先进的基因组编辑和纳米技术为有效的IRD治疗提供了新的希望.
科学领域:
- 眼科医生 眼科 眼科
- 遗传学 遗传学 是一个
- 生物技术是生物技术.
背景情况:
- 遗传性视网膜疾病 (IRD) 是导致视力丧失的遗传性疾病.
- 基因疗法,特别是基因增强,已经推进了IRD治疗.
- 现有的基因疗法面临局限性,包括对病毒载体的免疫反应.
研究的目的:
- 审查最近对IRDs的基因疗法进展.
- 探索当前IRD基因疗法的挑战和局限性.
- 突出新型基因组编辑和纳米技术方法用于IRD治疗.
主要方法:
- 对IRDs的基因治疗现有文献的综述.
- 对基因组编辑技术 (CRISPR-Cas9,基因编辑,主要编辑) 的分析.
- 在眼部基因传递中探索纳米技术应用.
主要成果:
- 基因疗法已经取得了进展,但面临着像免疫性等障碍.
- 基因组编辑工具为基因操纵提供了更高的精度.
- 纳米粒子可以改善基因传递,向和减少免疫反应.
结论:
- 基因组编辑和纳米技术的整合可以克服IRDs目前的基因治疗局限性.
- 这些先进的策略有望为IRD提供更安全,更有效的治疗方法.
- 这种方法也可能有利于其他眼部疾病.
相关概念视频
Gene Therapy
25.4K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.4K
CRISPR
50.4K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
50.4K
What is Genetic Engineering?
74.0K
Overview
74.0K
iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K


